title: High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results.
authors.forename: Angelo Michele
authors.initials: AM
authors.lastname: Carella
authors.forename: Monica
authors.initials: M
authors.lastname: Bellei
authors.forename: Pauline
authors.initials: P
authors.lastname: Brice
authors.forename: Christian
authors.initials: C
authors.lastname: Gisselbrecht
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Visani
authors.forename: Philippe
authors.initials: P
authors.lastname: Colombat
authors.forename: Francesco
authors.initials: F
authors.lastname: Fabbiano
authors.forename: Amedea
authors.initials: A
authors.lastname: Donelli
authors.forename: Stefano
authors.initials: S
authors.lastname: Luminari
authors.forename: Pierre
authors.initials: P
authors.lastname: Feugier
authors.forename: Peter
authors.initials: P
authors.lastname: Browett
authors.forename: Hans
authors.initials: H
authors.lastname: Hagberg
authors.forename: Massimo
authors.initials: M
authors.lastname: Federico
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D006801:Humans; D009367:Neoplasm Staging; D033581:Stem Cell Transplantation; D015996:Survival Rate; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D000970:Antineoplastic Agents